Recent Headlines
Within Pharmaceuticals
New GCP Training Aligned with ICH E6(R3) from Pharma Lessons
Pharma Lessons is pleased to announce the launch of its newly revised Good Clinical Practice (GCP) online training course, now fully aligned with the latest ICH GCP E6(R3) guidance. This update incorporates the key enhancements introduced by ICH E6(R3), including a stronger focus on risk-based... - October 14, 2025 - Pharma Lessons
Precision Antibody to Showcase Fully Human Monoclonal Antibody Development at the 19th Drug Discovery Strategic Summit in San Francisco
Precision Antibody will present its fully human monoclonal antibody development platform at the 19th Drug Discovery Strategic Summit, highlighting rapid, royalty-free antibody solutions advancing cancer research and drug discovery. - October 14, 2025 - Precision Antibody
Cellionyx Exits Stealth Mode with Cytomotion, an FDA-Registered Class I Electroceutical Device Set to Redefine Human Healing and Performance
Cellionyx today emerged from stealth to launch Cytomotion, a first-in-class, FDA-Registered Class I medical device. Shifting the paradigm to true cellular regeneration, Cytomotion utilizes precision-directed electrical fields to activate the body’s innate repair mechanisms. Validated through its licensee Equstech in the elite high performance equestrian sports market, the technology accelerates recovery from injury and proactively optimizes human performance. Commercial launch November 12, 2025. - October 13, 2025 - Cellionyx
IVC Hosts Charity Golf Tournament, Donates $100,000 to Support Local Communities
IVC proudly hosted its annual Charity Golf Tournament on October 8 at The Cliffs at Mountain Park Golf Club, bringing together employees, partners, and community members for a day of camaraderie, giving, and impact. As part of the event, IVC donated $50,000 each to March of Dimes in Anderson, SC,... - October 11, 2025 - International Vitamin Corporation
Radial Celebrates the Grand Opening of Its Second South Carolina Clinic in Downtown Conway
More than 60 community members and business leaders join for ribbon cutting ceremony with the Conway Chamber of Commerce. - October 11, 2025 - Radial
Abel Womack Launches Newly Redesigned Website
Enhancing Customer Experience Across Forklift, Automation, and Intralogistics Solutions - October 01, 2025 - Abel Womack Inc
Aquaterra Biotech Launches Integrated DNA-to-GMP CDMO Platform in Québec
Aquaterra Biotech Launches Integrated Microbial CDMO Platform from DNA Design to GMP Release Aquaterra Biotech announced an integrated contract development and manufacturing (CDMO) platform that advances microbial and recombinant programs from DNA design to GMP release and logistics. Headquartered... - September 30, 2025 - Aquaterra Biotech
The FOXG1 Research Foundation Announces FDA Award of Orphan Drug Designation for FRF-001 Gene Therapy, Following Rare Pediatric Disease Designation
The FOXG1 Research Foundation announced the FDA has granted Orphan Drug and Rare Pediatric Disease designations to FRF-001, its gene therapy for FOXG1 syndrome. FRF-001 marks a historic first: a parent-led foundation sponsoring its own international, multi-site clinical trial. - September 29, 2025 - FOXG1 Research Foundation
Alera Bio Announces Appointment of Executive Leadership Team
Alera Bio announced its executive team: Philip Vorhies (CEO), Peter Thomson (CFO), Eric Floyd, PhD (CRO), and Caitlin Murray (GC), supported by expert consultants. Founder Frank Jaeger noted their strength in biotech, finance, regulatory, and legal, positioning Alera to advance AB-101 for MCT-8 deficiency, a rare neurological disorder with FDA Rare Pediatric Disease designation. - September 26, 2025 - Alera Bio
Madison Avenue Group Announces Christine Nguyen as Official Partner
In 2021, Madison Avenue Group was founded with a clear mission: to help brands scale and grow through the power of influencer marketing. What began as a solo venture by founder Hollie Nguyen has now grown into a partnership built on strength, resilience, and vision. - September 26, 2025 - Madison Ave Group
New Chief Commercial Officer Joins Hemanext Team to Drive Execution
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, is pleased to welcome Mr. Shane Ray to the team as Chief Commercial Officer (CCO). In this role, Shane will lead the global commercial strategy and execution for Hemanext ONE®. - September 24, 2025 - Hemanext
Natural Cure Labs’ Level Off Gains Traction as Americans Seek Metabolic Health
Natural Cure Labs has updated its Level Off glucose support supplement to include loquat leaf extract, expanding the formula’s evidence base for healthier post-meal glucose balance. With only 12% of U.S. adults metabolically healthy, the enhancement underscores rising demand for natural solutions. - September 24, 2025 - Natural Cure Labs
French Biotech 4Dcell Selected to Showcase Next-Gen Cardiac Drug Testing Platform at EIC Corporate Day
French Startup 4Dcell Wins Spot to Show Next-Gen Cardiac Drug Testing Platform at EIC - September 24, 2025 - 4Dcell
October is Havana Syndrome Awareness Month
October is Havana Syndrome Awareness Month. The purpose is to raise awareness about Havana Syndrome injuries caused by directed energy. - September 23, 2025 - Havana Syndrome, Inc.
Wecan Engineering Solutions Expands Product Range with Innovative 3D Tumbler Mixer
Wecan Engineering Solutions, an established manufacturer of chocolate, food, and pharmaceutical machinery, proudly introduces its 3D Tumbler Mixer – a high-precision solution for uniform powder and granule mixing. The mixer operates on a multi-directional movement principle, which ensures complete blending without dead zones. Unlike conventional mixers, the 3D Tumbler Mixer gently handles materials, protecting particle integrity while delivering consistent results. - September 20, 2025 - Wecan Engineering Solutions
YOLO Immune Awarded National Science Foundation SBIR Grant to Advance Novel Immunotherapy for the Treatment of Autoimmune Diseases
YOLO Immune, Inc., a venture-backed biotech company developing precision immunotherapies for the treatment of serious human diseases, today announced it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF). The NSF SBIR program is... - September 19, 2025 - YOLO Immune Inc
Precision Antibody to Attend the World Clinical Biomarkers & CDx Summit 2025 in Boston
Precision Antibody will attend the World CDx Summit 2025 in Boston, showcasing its expertise in biomarker antibody development and contributions to NCI’s CPTC program, reinforcing its role in advancing precision medicine. - September 19, 2025 - Precision Antibody
Creative Biolabs Finds a Way Out to Vitalize Functional Antibody Development
Creative Biolabs introduces how functional antibody development and supply are shaping biotech solutions and demonstrates solutions and scholarship opportunities. - September 19, 2025 - Creative Biolabs
Alera Bio Launches Lead Rare Disease Program with Exclusive Rights to MCT-8 Deficiency Therapy
Alera Bio secures exclusive license to advance AB-101, a first-in-class program for MCT-8 deficiency, with FDA Rare Pediatric Disease designation already in place. - September 18, 2025 - Alera Bio
Hospitality Veteran Brent O’Connor Joins PDS to Lead High-Impact Event Solutions Across Western Canada
Pacific Destination Services (PDS) has appointed Brent O’Connor as Sales Director, Corporate Hospitality & Events. With over 30 years of hospitality sales and marketing experience at brands like Sheraton, Westin, and Shangri-La, Brent will lead corporate sales strategies and deliver innovative event solutions across Western Canada. Recognized for driving revenue growth and building high-performing teams, his appointment comes as Vancouver prepares for major global events. - September 17, 2025 - Pacific Destination Services
BioSensics Awarded $5.2M NIH Grant to Advance Digital Biomarkers for PSP and DLB
BioSensics has received a 5-year/$5.2 million grant from the National Institutes of Health (NIH) to develop and validate novel digital biomarkers of disease activity in progressive supranuclear palsy (PSP) and dementia with Lewy bodies (DLB). This 5-year project will leverage BioSensics’ expertise in wearable sensors and digital health technologies and involve close collaboration with leading CurePSP Centers of Care and patient advocacy groups. - September 17, 2025 - BioSensics LLC
Dr. David Pincus of Pincus Plastic Surgery Named #1 Plastic Surgeon in New York and Florida by Hippo Medical
Board-Certified Plastic Surgeon Dr. David Pincus, founder of Pincus Plastic Surgery, has been honored with the America’s Top Plastic Surgeon Award by Hippo Medical, recognizing him as the #1 plastic surgeon in both New York and Florida for his excellence in patient safety, surgical artistry, and natural aesthetic results. - September 17, 2025 - Pincus Plastic Surgery
Microtrace Advances Product Authentication: Protect Revenue, Strengthen Brand Trust, and Enhance Operational Efficiency
Proprietary solutions secure device-consumable ecosystems, protect revenue streams, and deliver measurable business impact for global manufacturers. - September 16, 2025 - Microtrace LLC
Longevity World Cup Launches: A Global Sport Where Age is the Advantage
The Longevity World Cup, launching September 16, 2025, is the first global competition where athletes win by reversing their biological age. Rankings are based on verified tests using the PhenoAge clock, with categories by gender and generation. Prize money, funded in Bitcoin, goes to the top athletes. - September 16, 2025 - Longevity World Cup
Wecan Engineering Solutions Expands Global Reach with Innovative Chocolate, Food and Pharma Machinery
Founded in Gujarat, India, Wecan Engineering Solutions is a leading manufacturer and exporter of chocolate, food, and pharmaceutical machinery. With over seven years of expertise, the company has built a reputation for innovation, quality, and customer trust. Its vision is to deliver advanced engineering solutions that support the growth of food and pharmaceutical industries worldwide. - September 12, 2025 - Wecan Engineering Solutions
Lyfe RX Launches New Brand Identity, Bringing Science-Backed Wellness Solutions to Consumers Nationwide
Lyfe RX, formerly Live Well RX, announces its official rebrand and launch, introducing a fresh identity and expanded wellness offerings. With personalized weight management, peptide therapies, doctor-curated supplements, and high-protein meal prep, Lyfe RX delivers comprehensive, science-backed solutions to help customers achieve their health, longevity, and wellness goals. - September 10, 2025 - The Lyfe RX
National Brain Tumor Society Appoints Renowned Pediatric Oncologist as Chief Scientific Officer
National Brain Tumor Society names leading pediatric cancer expert, Dr. Susan Blaney, as new Chief Scientific Officer. - September 08, 2025 - National Brain Tumor Society
From Customer to CEO: Kaitlyn Talamante Acquires LadyBoss, the Women’s Health Brand Empowering Hundreds of Thousands Since 2014
LadyBoss, the women’s health and lifestyle brand founded in 2014 by Kaelin and Brandon Poulin, later sold to Russell Brunson in 2022, announces its new owner, Kaitlyn Talamante. A former LadyBoss customer turned CEO, Talamante’s journey from personal transformation to leading the brand represents a full-circle story of empowerment, growth, and vision for the future. - September 05, 2025 - LadyBoss
APTMetrics Welcomes Dr. Doug Reynolds and Dr. Matt Paese
APTMetrics, a talent management consultancy that enables organizations to unlock workforce and leadership potential through proven, AI-powered people science, announced today that Dr. Doug Reynolds and Dr. Matt Paese will be joining its leadership team. Dr. Reynolds will take on the role of... - September 04, 2025 - APTMetrics
GetReal Security Named Winner for Real-Time Threat Mitigation in the SiliconANGLE TechForward Awards
GetReal Security, the cybersecurity leader specialized in mitigating digital identity threats posed by malicious generative AI (GenAI) content, today announced it has been named the Real-Time Threat Mitigation Winner in SiliconANGLE’s inaugural 2025 TechForward Awards, and recognized as a... - August 26, 2025 - GetReal Security
Liminatus Pharma Announces Receipt of Nasdaq Listing Delinquency Letter
Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”), a pre-clinical stage biopharmaceutical company developing novel, immune-modulating cancer therapies, today announced that on August 22, 2025, it received a notification letter from Nasdaq indicating that... - August 26, 2025 - Liminatus Pharma, Inc
DDi added more AI Agents to enhance Regulatory Strategy, Planning, and Project Actions
DDi introduces AI Agents for Strategy, Planning, and Actions, including Regulatory Insights, Regulatory Impact, and Planning Agents. These tools provide compliance visibility, assess regulatory impacts, and optimize planning, enabling organizations to act with confidence and agility. - August 22, 2025 - DDi LLC
AcCELLerated Biologics to Distribute RegenaLase™ Laser System from IPG Medical Corporation Across the United States
AcCELLerated Biologics, LLC, a leading distributor of regenerative medicine technologies, today announced an exclusive agreement with IPG Medical Corporation, a wholly owned subsidiary of IPG Photonics Corporation, to distribute the RegenaLase™ Laser System throughout the United States. This... - August 20, 2025 - AcCELLerated Biologics
Co-Investigator of Clinical Safety Study Presents at EHA
Hemanext Inc., a leading innovator in blood processing, storage, and transfusion technology, announces that the data from its safety study was accepted in the form of an oral presentation at the European Hematology Association 2025 Congress that took place in Milan, Italy on June 12-15. - August 19, 2025 - Hemanext
CABRI Fellowship Program Opens for Undergraduate Research Applicants
The Cayman Biomedical Research Institute (CABRI) has announced that applications are now open for their undergraduate research fellowships. Applications may be submitted on the CABRI website from August 11, 2025 through September 29, 2025. - August 15, 2025 - Cayman Chemical Company
New Book “Life Lessons From the Overhead Bin: A Flight Attendant’s Advice on How to Be Fit, Fearless and Fulfilled After 50” Uplifts and Inspires Women to Soar in Midlife
In her debut book, author Helen Fritsch weaves observations and stories from her 40-year career in the sky with her unique inspirational advice and practical tips. - August 14, 2025 - Helen Fritsch
Peernovation Readiness Survey Now Available Online
By visiting Peernovation.biz/about and scrolling to the bottom, CEOs, HR professionals, and team leaders can now access a free, one-minute Peernovation Readiness Survey online. Peernovation helps leaders bring the proven best practices from CEO Forums to their organizations to create happier, higher-performing teams in this fast-changing world. - August 06, 2025 - Peernovation, LLC
Global Multiple Myeloma Therapeutics Market and Forecast to 2030
Apelo Consulting has released a report on Global Multiple Myeloma Therapeutics Market (By Disease, Treatment, Route of Administration, End User, Regional Analysis), Company Profiles, Market Dynamics and Recent Developments – Forecast to 2030. - July 31, 2025 - Apelo Consulting Pvt. Ltd.
YOLO Immune Inc. Emerges from Stealth Mode
YOLO Immune Inc. has emerged from stealth mode to unveil its human-centric drug discovery process and to announce the promotion of its founding research team. YOLO Immune is a venture-backed biotech company developing precision immunotherapies for the treatment of serious human diseases. The... - July 31, 2025 - YOLO Immune Inc
Ugandan Student Launches Hope.co.ug to Help People Ask Health Questions Online
Hope Emmanuel, a pharmacy student and tech enthusiast, has launched Hope.co.ug — a platform where Ugandans can ask health questions and receive clear, reliable answers in everyday language. - July 28, 2025 - Hope.co.ug
ERBESSD INSTRUMENTS Continues Global Expansion
ERBESSD INSTRUMENTS a global leader in dynamic balancing, vibration analysis, machinery health, and process health instrumentation and optimization announces expansion to Latin America. - July 25, 2025 - ERBESSD INSTRUMENTS
Hemanext Announces Close of Series B3 Equity Financing Round
Hemanext Inc., a leading innovator in blood processing, storage and transfusion technology, announced the close of its Series B-3 equity financing round. The round raised $18.9 million at a post-money valuation of $172 million or $0.275 per share, with support from new investors and repeat investments from those participating in the Series B-2 capital round. - July 22, 2025 - Hemanext
GENINVO Celebrates 8 Years of Innovation and Growth in the Life Sciences Industry
GENINVO, a leading provider of transformative digital solutions for the life sciences sector, proudly celebrates its 8th anniversary—a journey marked by innovation, collaboration, and impactful contributions across global healthcare and pharmaceutical domains. From a vision sparked eight... - July 22, 2025 - GenInvo, Inc.
Mind-Sync Launches Strategic Fundraising Round to Transform Long-Term Care Operations with AI-Driven Platform
Mind-Sync, an emerging leader in AI-powered healthcare technology, announced today the launch of a strategic fundraising round aimed at accelerating its mission to modernize operations in long-term care, assisted living, and memory care communities across the U.S. Mind-Sync’s founders... - July 19, 2025 - Mind-Sync, LLC
Enigma Networks Launches from Stealth to Deliver the First ZTNX Platform - Zero Trust for Internal Networks
Enigma Networks is pioneering ZTNX — Zero Trust for Internal Networks. Their agentless platform, Enigma AI, gives security teams real-time visibility into east-west traffic, discovers every asset, detects lateral movement, and enforces segmentation. Built for hybrid environments, Enigma AI eliminates internal blind spots and brings Zero Trust to where it’s needed most — inside the network. - July 15, 2025 - Enigma Networks Inc.
Phenotap, Inc. Receives Progr. Related Investment from Helmsley Charitable Trust to Advance Breakthrough Ketone Sensor Technology for People Living with Type 1 Diabetes
Phenotap, Inc. announced a $3 million investment to support the continued development and optimization of KetoTap™ Core, a novel enzymatic technology, to make it active and stable enough to be used as part of a continuous ketone sensor that can help prevent the occurrence of diabetic ketoacidosis (DKA) for people living with type 1 diabetes (T1D). - July 14, 2025 - Phenotap, Inc.
"RediPlate" Metabolism Assay Kits from AkrivisBio
AkrivisBio is thrilled to announce the launch of a new concept in assay kits, “RediPlate,” a patent pending design in which all the assay components are already applied to the wells. The end user has to merely rehydrate the well, add the sample and start reading. RediPlate kits are designed to enhance reproducibility, easy to use, and deliver faster, more accurate results. RediPlate kits are built to support your research work from discovery to validation. - July 14, 2025 - AkrivisBio
Aphora Health Acquires CareNexis to Accelerate Innovation in Specialty Pharmacy Benefits and AI-Driven Insights for Self-Insured Employers
Aphora Health, a leading provider of cost containment solutions and advanced pharmacy benefit strategies for self-insured employers, announces the acquisition of CareNexis, a digital health company known for its proprietary consumer health intelligence and engagement platform. This acquisition... - July 10, 2025 - Aphora Health
Precision Antibody to Attend and Present at Interphex Regenerative Medicine 2025 in Tokyo
Precision Antibody will attend Interphex Regenerative Medicine 2025 in Tokyo from July 9–11. Dr. Jun Hayashi will present on fully human antibody development, highlighting the company’s commitment to global collaboration and therapeutic innovation. - July 09, 2025 - Precision Antibody
Alera Bio Launches to Advance Breakthrough Therapies for Rare Neurological Disorders
Chicago-based Alera Bio has launched with a mission to develop treatments for ultra-rare and neglected neurological disorders, especially in children. Combining scientific innovation with patient urgency, the company will pursue both novel and repurposed therapies via orphan drug and 505(b)(2) pathways. With a lean, capital-efficient model, Alera Bio aims to rapidly advance therapies that address critical gaps in care. - July 03, 2025 - Alera Bio